NO20055010L - Preparater inneholdende laktulose for behandling av potavirusinfeksjoner - Google Patents

Preparater inneholdende laktulose for behandling av potavirusinfeksjoner

Info

Publication number
NO20055010L
NO20055010L NO20055010A NO20055010A NO20055010L NO 20055010 L NO20055010 L NO 20055010L NO 20055010 A NO20055010 A NO 20055010A NO 20055010 A NO20055010 A NO 20055010A NO 20055010 L NO20055010 L NO 20055010L
Authority
NO
Norway
Prior art keywords
infections
potavirus
treatment
preparations containing
lactulose
Prior art date
Application number
NO20055010A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055010D0 (no
Inventor
Mary Locniskar
Bryon Waller Petschow
Robert Alexander Burns
Virginia Sue Sickles
James Wayne Hansen
Steven Charles Rumsey
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20055010D0 publication Critical patent/NO20055010D0/no
Publication of NO20055010L publication Critical patent/NO20055010L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30Artificial sweetening agents
    • A23L27/33Artificial sweetening agents containing sugars or derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25Synthetic polymers, e.g. vinylic or acrylic polymers
    • A23L33/26Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20055010A 2003-03-28 2005-10-27 Preparater inneholdende laktulose for behandling av potavirusinfeksjoner NO20055010L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/401,390 US20040191295A1 (en) 2003-03-28 2003-03-28 Composition and method for viral inhibition
PCT/US2004/008356 WO2004093885A1 (en) 2003-03-28 2004-03-19 Compositions containing lactulose for treating potavirus infections

Publications (2)

Publication Number Publication Date
NO20055010D0 NO20055010D0 (no) 2005-10-27
NO20055010L true NO20055010L (no) 2005-12-27

Family

ID=32989437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055010A NO20055010L (no) 2003-03-28 2005-10-27 Preparater inneholdende laktulose for behandling av potavirusinfeksjoner

Country Status (13)

Country Link
US (3) US20040191295A1 (pt)
EP (1) EP1613331A1 (pt)
KR (1) KR20060002886A (pt)
CN (1) CN1795000A (pt)
AR (1) AR043937A1 (pt)
BR (1) BRPI0408882A (pt)
CA (1) CA2520647A1 (pt)
CL (1) CL2004000652A1 (pt)
MX (1) MXPA05010274A (pt)
NO (1) NO20055010L (pt)
RU (1) RU2005133224A (pt)
TW (1) TW200503735A (pt)
WO (1) WO2004093885A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1673987A1 (en) * 2004-12-23 2006-06-28 N.V. Nutricia Temporally meal menu for infants
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
AR057623A1 (es) 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
CA2675230A1 (en) * 2006-01-10 2008-07-26 Pipex, Inc. Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2011081509A1 (es) * 2009-12-29 2011-07-07 Chavez Gabriela Composiciones nutricionales que comprenden hojuelas de frutas que incluyen ácido docosahexaenoico
US20110189342A1 (en) * 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
CN101843893B (zh) * 2010-05-21 2012-02-01 中国人民解放军第三军医大学 环孢素a在制备抗轮状病毒药物中的应用
FR2961378A1 (fr) * 2010-06-22 2011-12-23 Solvay Effet prebiotique d'oligosaccharides
DK2658399T4 (da) 2010-12-31 2024-03-25 Abbott Lab Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
MY196432A (en) 2010-12-31 2023-04-10 Abbott Lab Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
BR112013016587A2 (pt) 2010-12-31 2016-09-27 Abbott Lab formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
BR112013016903A2 (pt) 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para modular inflamação
WO2018197087A1 (en) * 2017-04-28 2018-11-01 Fresenius Kabi Austria Gmbh Compositions comprising lactulose for maintaining or improving gut health in humans
DE102019003442A1 (de) 2019-05-15 2020-11-19 Ilma biochem GmbH Verwendung von niedermolekularen glykosidisch gebundenen endständigen Galactosiden und Fucosiden zur Bindung von als Galectin wirkenden Toxinen im Rahmen der Behandlung von Vergiftungen, insbesondere bei Vergiftungen mit Ricin
EP4125888A1 (en) * 2020-03-24 2023-02-08 Bausch Health Ireland Limited Solid dispersions of rifaximin for the treatment of overt hepatic encephalopathy
WO2025151941A1 (pt) * 2024-01-18 2025-07-24 Moro Peres Nemecio Suplemento alimentar indicado para tratamento de doenças hepáticas à base de fosfatidilcolina, capsula compreendendo dito suplemento e uso do mesmo
CN119464229B (zh) * 2025-01-07 2025-05-06 北京义翘神州科技股份有限公司 一种组合物及其在抑制逆转录病毒失活中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272705A (en) * 1963-06-13 1966-09-13 Philips Corp Laxative composition and method of using same
JPS4944331B1 (pt) * 1971-05-31 1974-11-27
BE890753R (nl) * 1981-10-16 1982-04-16 Denecker Jan Therapeutische compositie voor het behandelen van dieren, namelijk duiven
JPS62138147A (ja) * 1985-12-12 1987-06-20 Snow Brand Milk Prod Co Ltd ガラクトオリゴ糖類配合飼料
US4987124A (en) * 1987-10-13 1991-01-22 Coors Biotech, Inc. Method for inhibiting the growth of salmonella
US5439893A (en) * 1993-05-26 1995-08-08 University Of Montana Methods for the treatment and prevention of diarrhea
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5658893A (en) * 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE69506095T2 (de) * 1995-08-04 1999-06-24 Naamloze Vennootschap Nutricia, Zoetermeer Diätfasern enthaltende Nahrungszusammensetzung
RU2157639C1 (ru) * 1999-06-22 2000-10-20 Московский государственный университет прикладной биотехнологии Способ производства кисломолочного продукта
RU2187229C1 (ru) * 2001-04-09 2002-08-20 Государственное научное учреждение Научно-исследовательский институт детского питания РАСХН Кисломолочный продукт для детского питания с рождения до пяти месяцев жизни
RU2189753C1 (ru) * 2001-04-09 2002-09-27 Государственное научное учреждение Научно-исследовательский институт детского питания РАСХН Стерилизованный молочный продукт для детского питания с рождения до пяти месяцев
RU2196432C1 (ru) * 2001-06-29 2003-01-20 Государственное научное учреждение Научно-исследовательский институт детского питания РАСХ Композиция для приготовления кисломолочного продукта геродиетического питания

Also Published As

Publication number Publication date
WO2004093885A9 (en) 2006-06-29
AR043937A1 (es) 2005-08-17
US20050014717A1 (en) 2005-01-20
RU2005133224A (ru) 2006-02-27
CN1795000A (zh) 2006-06-28
NO20055010D0 (no) 2005-10-27
CA2520647A1 (en) 2004-11-04
US20040191295A1 (en) 2004-09-30
MXPA05010274A (es) 2005-11-17
TW200503735A (en) 2005-02-01
US20050276838A1 (en) 2005-12-15
WO2004093885A1 (en) 2004-11-04
CL2004000652A1 (es) 2005-05-27
EP1613331A1 (en) 2006-01-11
KR20060002886A (ko) 2006-01-09
BRPI0408882A (pt) 2006-04-11

Similar Documents

Publication Publication Date Title
NO20055010L (no) Preparater inneholdende laktulose for behandling av potavirusinfeksjoner
AR076862A1 (es) Microorganismos no replicantes y su efecto de refuerzo inmunologico. composicion. metodo para aumentar efectividad de probioticos
Berger et al. Exudative glutamine losses contribute to high needs after burn injury
SE0950390L (sv) System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför
PL1684719T3 (pl) Kompozycje alfa 1-antytrypsyny i sposoby leczenia z zastosowaniem takich kompozycji
Rossi et al. Overview on cranberry and urinary tract infections in females
WO2021240293A1 (en) Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system
Mukherjee et al. Exploring the role of cranberry polyphenols in periodontits: A brief review
Hardy et al. Nutraceuticals: a pharmaceutical viewpoint: I
US20210315930A1 (en) Nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation
US8298597B2 (en) Composition to help protect a user against liver damage from alcohol consumption
Nand et al. Prevalence of hyperhomocysteinaemia in chronic kidney disease and effect of supplementation of folic acid and vitamin B12 on cardiovascular mortality
US20110256237A1 (en) Methods and compositions for treating acne vulgaris and acne rosacea
WO2017024639A1 (zh) 中药解酒制剂
Tully et al. Immunonutrition and supplementation: pathways, promise, and pessimism
Parikh et al. Improving Iron Bioavailability with Prebiotic Galacto‐Oligosaccharides
Rhee et al. Anti-Helicobacter pylori effect of CaG-NANA, a new sialic acid derivative
Sierra-Hoffman et al. Daptomycin and ampicillin combination for treatment of enterococcus faecalis endocarditis
US20150164928A1 (en) Pharmaceutical composition for the regeneration of the liver
Babu The ideal zinc preparation in the management of acute diarrhea in children
KR20230066358A (ko) 바이러스 감염을 치료하기 위한 조성물 및 방법
TH78323A (th) ส่วนประกอบและวิธีการที่ใช้ในการยับยั้งไวรัส
Lei et al. LB025-SUN EFFECT OF ENTERAL PHARMACONUTRITION ON ORGAN DYSFUNCTION IN SEPTIC PATIENTS
Stafford A New B Vitamin and Pernicious Anemia
Cortes et al. LB024-SUN NUTRITION DAY IN COLOMBIA: HOW ARE WE???